This Morning's Technical Outlook on Healthcare Information Services Stocks -- Premier, Medical Transcription Billing, Cerner, and Evolent Health

Monday, November 27, 2017 General News
Email Print This Page Comment bookmark
Font : A-A+

NEW YORK, November 27, 2017 /PRNewswire/ --

In keeping with the commitment to dynamically provide members with timely

information has issued free tailored Stock Review on PINC, MTBC, CERN, and EVH which is a click away at On Friday, benchmark US indices were in bullish colors as the NASDAQ Composite
closed the trading session up 0.32%; the Dow Jones Industrial Average edged 0.14% higher; and the S&P 500 was up 0.21%. US markets made broad based gains with all sectors finishing the day in green. Pre-market today, reviews these four Healthcare Information Services stocks: Premier Inc. (NASDAQ: PINC), Medical Transcription Billing Corp. (NASDAQ: MTBC), Cerner Corp. (NASDAQ: CERN), and Evolent Health Inc. (NYSE: EVH). With Wall St. Equities' free research reports get an edge over stock markets, sign up now at:


Charlotte, North Carolina headquartered Premier Inc.'s stock finished Friday's session 0.67% lower at $28.31. A total volume of 734,539 shares was traded, which was above its three months average volume of 601.53 thousand shares. The stock is trading below its 50-day moving average by 11.50%. Furthermore, shares of Premier, which together with its subsidiaries, operates as a healthcare improvement company in the US, have a Relative Strength Index (RSI) of 33.91. Our free and thorough report on PINC awaits you at:

Medical Transcription Billing 

Shares in Somerset, New Jersey headquartered Medical Transcription Billing Corp. ended at $2.61, down 2.97% from the last trading session. The stock recorded a trading volume of 154,487 shares. The Company's shares have gained 82.52% over the previous three months, 193.26% in the last twelve months, and 260.00% on an YTD basis. The stock is trading above its 50-day and 200-day moving averages by 2.40% and 65.23%, respectively. Moreover, shares of the Company, which provides an integrated suite of Web-based solutions and related business services to healthcare providers primarily in the US, have an RSI of 50.86.

On November 14th, 2017, research firm Chardan Capital Markets reiterated its 'Buy' rating on the Company's stock with an increase of the target price from $2.25 a share to $2.75 a share. MTBC complimentary research coverage a few simple steps away at:


North Kansas City, Missouri headquartered Cerner Corp.'s stock ended last Friday's session 0.77% higher at $70.57 with a total trading volume of 2.05 shares. The Company's shares have advanced 39.71% in the last twelve months and 48.98% on an YTD basis. The stock is trading above its 50-day and 200-day moving averages by 1.78% and 9.92%, respectively. Additionally, shares of Cerner, which designs, develops, markets, installs, hosts, and supports health care information technology, health care devices, hardware, and content solutions for health care organizations and consumers in the US and internationally, have an RSI of 64.51.

On November 02nd, 2017, research firm RBC Capital Markets downgraded the Company's stock rating from 'Top Pick' to 'Outperform' while revising its previous target price from $84 a share to $74 a share. Are you already registered with Wall St. Equities? Do so now for free, and get the report on CERN at:

Evolent Health 

On Friday, shares in Arlington, Virginia headquartered Evolent Health Inc. recorded a trading volume of 756,445 shares. The stock finished the day 0.82% lower at $12.05. The stock is trading below its 50-day moving average by 21.42%. Furthermore, shares of Evolent Health, which through its subsidiary, Evolent Health LLC, provides healthcare delivery and payment solutions in the US, have an RSI of 39.41. Aspiring Member, please take a moment to register below for your free research report on EVH at:


Wall St. Equities: 

Wall St. Equities (WSE) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. WSE has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below. 

WSE has not been compensated; directly or indirectly; for producing or publishing this document. 


The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third-party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by WSE. WSE is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.  


WSE, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. WSE, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, WSE, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice. 


This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither WSE nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit

CONTACT For any questions, inquiries, or comments reach out to us directly. If you're a company, we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at: Email: Phone number: 21-32-044-483 Office Address: 1 Scotts Road #24-10, Shaw Center Singapore 228

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE Wall St. Equities

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store